Cogent Biosciences Reports Positive Results from Bezuclastinib PEAK Phase 3 Trial in Gastrointestinal Stromal Tumors (GIST)
quantisnow.com/i/cogent-biosciences-reports-p...Posted Nov 10, 2025, 12:03 PM UTC
10
quantisnow.com
Loading comments…
Posted Nov 10, 2025, 12:03 PM UTC